
Primerica (PRI) Stock Forecast & Price Target
Primerica (PRI) Analyst Ratings
Bulls say
Primerica has demonstrated robust growth across several key metrics, notably a 4% increase in new policies issued, reaching 100,768, and a significant 29% surge in Investment and Savings Products (ISP) sales to $3.1 billion. The company's Term Life segment revenues for the second quarter reached $427 million, which aligns well with projections, contributing to a total operating revenue of $753 million that exceeded both internal forecasts and consensus estimates. Furthermore, the expansion of the salesforce by 6% year-over-year, alongside an expected 15% growth in ISP sales for 2024, suggests a positive trajectory for the company's future performance.
Bears say
Primerica Inc faces several risks that contribute to a negative outlook on its stock, including potential slow growth in new recruitment which could adversely affect its overall salesforce, alongside an increased mortality rate in its Life segment that may hinder profitability. The company reported a significant $254 million write-off of goodwill and intangibles related to its Senior Health operations, highlighting potential underlying issues. Additionally, Primerica's price-to-earnings ratio appears elevated compared to its peers in the life insurance sector, further raising concerns about its valuation amidst an uncertain financial environment.
This aggregate rating is based on analysts' research of Primerica and is not a guaranteed prediction by Public.com or investment advice.
Primerica (PRI) Analyst Forecast & Price Prediction
Start investing in Primerica (PRI)
Order type
Buy in
Order amount
Est. shares
0 shares